top of page

JIMT-1 Xenograft Model

Rincon Bio offers efficacy studies using the JIMT-1 Xenograft Model at our U.S.-based facilities, with direct access to the scientists conducting your study.

Model Type:
Xenograft
Organ:
Breast
Derivation:
Breast ductal carcinoma of a 62yo female. ER negative, ERBB2 amplification, herceptin-resistant
Mutations:
PIK3CA, TP53
NCI60:
No
Weeks from stratification to termination (average):
8

JIMT-1 Growth Curve

(Representative of studies performed at Rincon Bio)

Representative tumor growth curve for the JIMT-1 xenograft model from studies performed at Rincon Bio.

For more information on this model, including available control data, please Contact Us, or request a Quote below

All Xenograft Models

All Syngeneic Models

bottom of page